씨엔에스대부

비상장계속사업자

CNS

구본영

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

씨엔에스대부

Business Reg. No. 2208750522 · CEO 구본영

I.Investment Overview

Target씨엔에스대부 (2208750522)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명씨엔에스대부
영문명CNS
대표자구본영
사업자등록번호2208750522
법인등록번호1101113704677
설립일2007.06.25
종업원수40명

V.Workforce

40

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW113.1202093.3202179.7202259.3202455.12025
영업이익100M KRW84.1202062.3202153.2202218.4202419.22025
순이익100M KRW32.9202047202141.5202216202424.52025
Item20252024202220212020
자산총계400.5억원319.4억원250.8억원306.9억원230.3억원
부채총계186.7억원80.1억원25.1억원112.6억원73.1억원
자본총계213.8억원239.3억원225.7억원194.2억원157.2억원
매출액55.1억원59.3억원79.7억원93.3억원113.1억원
영업이익19.2억원18.4억원53.2억원62.3억원84.1억원
순이익24.5억원16억원41.5억원47억원32.9억원

VII.Financial Ratios

FY2025 basis

34.93%

영업이익률

44.59%

순이익률

6.13%

ROA

11.48%

ROE

87.29%

부채비율

53.39%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

씨엔에스대부 투심보고서 | Alpha Lenz